State Veterans Home Presentation Behaviors

Download Report

Transcript State Veterans Home Presentation Behaviors

National Partnership to Improve Dementia Care
Denise F. O’Donnell, RN, MN, GCMS-BC, MASM, NHA
Nurse Consultant/ Division of Nursing Homes/Survey
and Certification Group
March 3, 2016
1
Presentation Goals
Participants will:
• Be knowledgeable about the CMS National Partnership to Improve
Dementia Care in Nursing Homes and achievements to date in
improving dementia care and reducing the use of antipsychotic
medications.
• Be able to identify resources that CMS and their partners have
developed to assist facilities in improving dementia care.
• Learn about the Focused Dementia Care Surveys and how they are
impacting care.
• Be able to utilize the information shared regarding practice issues for
use in the State Veterans Homes.
2
Partnership Mission
Mission:
• Improve the quality of care provided to individuals with dementia
living in nursing homes.
• Deliver health care that is person-centered, comprehensive and
interdisciplinary.
• Protect residents from being prescribed antipsychotic
medications unless there is a valid, clinical indication and a
systematic process to evaluate each individual.
3
Partnership Overview
• CMS promotes a multidimensional approach through:
–Research
–Partnerships and state-based coalitions
–Surveyor guidance
–Education
–Public reporting
• The 3 R’s:
• Rethink our approach to dementia care.
• Reconnect with residents via person-centered care practices.
• Restore good health and quality of life.
4
CMS Collaborative Efforts
•
Bi-Annual calls with State Coalitions
•
MLN Connects ® (Medicare Learning Network) National Provider Calls
https://www.cms.gov/Outreach-and-Education/Outreach/NPC/National-Provider-Calls-and-Events.html
•
National Partnership resource repository – Advancing Excellence
https://www.nhqualitycampaign.org/dementiaCare.aspx
http://www.cms-handinhandtoolkit.info/
•
Grants – Use of Federal Civil Monetary Penalty Funds
https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/Survey-and-Cert-Letter-1534.pdf
•
Focused Dementia Care Surveys
5
Measuring Progress
CMS is tracking the progress of the Partnership by reviewing publicly
reported measures.
The official measure of the Partnership is the percentage of long-stay
nursing home residents receiving an antipsychotic medication,
excluding residents with Schizophrenia, Huntington's Disease or
Tourette’s Syndrome.
6
Partnership Goals
• Reduce the national prevalence of antipsychotic medication use in long-stay
nursing home residents:
– Initial goal by 15%
– By 25 percent by the end of 2015
– By 30 percent by the end of 2016
• Discover ways to implement new practices:
– To enhance quality of life.
– To protect residents from substandard care.
– To promote goal-directed, person-centered care approaches.
www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2014-Press-releases-items/2014-09-19.html
http://
7
Current Data Trends: Progress to Date
Source: CMS Quality Measure, based on MDS 3.0 data. For more information see the MDS 3.0 Quality Measures Users Manual
8
Quarterly Prevalence of Antipsychotic Use for Long-Stay Residents,
CMS Regions 2011Q2 to 2015Q3
Source: CMS Quality Measure, based on MDS 3.0 data. For more information see the MDS 3.0 Quality Measures Users Manual
9
Quarterly Prevalence of Antipsychotic Use for Long-Stay Residents,
CMS Regions 2014Q1 to 2015Q3
Region
National
2014 2015Q1 2015Q2 2015Q3
Q4
19.1% 18.68 17.96
17.43
Percentage point
difference
% Change
(2011Q4-2015Q3)
-6.44 -27.0%
Region 01 19.6 19.12
%
Region 02 16.1% 15.72
18.40
18.09
-8.13 -31.0%
14.92
14.65
-5.43 -27.0%
Region 03 17.1% 16.88
16.16
16.08
-5.73 -26.3%
Region 04 20.0 19.60
%
18.77
18.24
-7.27 -28.5%
Source: CMS Quality Measure, based on MDS 3.0 data. For more information see the MDS 3.0 Quality Measures Users Manual
10
State Veterans Homes Data Q4 2015
Mean % of Reported Daily Psychoactive Drug Use (Q4 2015)
Veterans Nursing
Homes
(N=69)
All Nursing Homes
(N=14,294)
Anti-depressant (AD)
50.2%
49.2%
Anti-psychotic (AP)
17.4%
19.1%
Anti-anxiety (AX)
12.4%
15.9%
Hypnotic (HP)
2.1%
2.6%
Type of Psychoactive Drug
Data taken from CASPER and the MDS Q4 2015 for psychoactive drug use.
11
Enforcement
• Analysis of survey citations as of March 2014 reflects:
- A slight increase in % of NH residents with
Schizophrenia coded on the MDS
- A small decrease in use of sedatives/hypnotics used in
facilities
-Continued reduction in antipsychotic medication
usage overall.
12
2014 Focused Dementia Care Survey Pilot
• To optimize survey efficiency and effectiveness.
• To more thoroughly examine the process for prescribing antipsychotic
medication, as well as other dementia care practices in nursing homes.
• To gain new insights about surveyor knowledge, skills and attitudes
related to the care of people with dementia.
• To determine ways that the current survey process may be streamlined to
more efficiently and accurately identify and cite deficient practice.
• To recognize successful dementia care programs.
13
2015 Focused Dementia Care Survey
Expansion Effort
• S&C Memo 15-31-NH invited States to conduct surveys on a
voluntary basis.
• More intensive, targeted effort to improve surveyor
effectiveness in citing poor dementia care and the
overutilization of antipsychotic medications.
• Conducted as surveys of record.
• Deficient practices were cited and standard enforcement
procedures followed, including revisits.
14
Surveyor Feedback
• Facilitated compliance with dementia care
standards.
• Deficient practices were easily identified.
• Provided opportunity for surveyors to “zero-in”
on dementia care practices.
• Expected timeframe for completion of survey
was reasonable, if three surveyors participated
and no serious issues were identified.
15
Challenges Identified
Surveyors identified the following as the most challenging
aspects of the process:
–Facility system problems;
–Completing necessary observations;
–Amount of time spent in educating; and
–Lack of training.
16
Focused Dementia Care Survey Tools
• CMS received feedback from stakeholders and partners.
• Revised survey materials were shared via Survey &
Certification Memo 16-04-NH.
https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertificationGenInfo/Downloads/Survey-and-Cert-Letter-16-04.pdf
• Facilities encouraged to use the tools to assess their own
practices in providing resident care.
17
Next Steps
• Release of final report for 2015 Focused Dementia Care
Surveys.
• Complete additional Focused Dementia Care Surveys in
2016.
– Focus on nursing homes that continue to have high rates of
antipsychotic medication use.
• Continue review of dementia care practices in standard
survey process, both Traditional and QIS.
18
State Veterans Homes
• Unique and challenging population
• Age groups
• Diagnoses
• Behavioral and psychosocial issues
• Resources
• Regulatory and survey issues
19
Strategies for Success in Reducing the Use of
Antipsychotic Medications
•
•
•
•
•
•
•
Commitment at all levels;
Multidisciplinary approach;
Increased knowledge for all levels of staff;
Documentation;
Utilization of all available resources;
Self monitoring; and
Research.
20
Questions?
21
Thank You
• For more information about the National Partnership, please visit:
https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertificationGenInfo/National-Partnership-to-ImproveDementia-Care-in-Nursing-Homes.html
• Please send questions, via email to: [email protected]
22